Investing in Life Sciences Technology

 

Our Story

Biospring Partners was founded in 2020 by Michelle Dipp, MD PhD and Jennifer Lum to invest in growth-stage life sciences technology companies. Biospring leverages its deep experience in life sciences and technology to support B2B services, tools, and enterprise software companies that are driving innovation across the life sciences industry.

 

Our Team

Michelle Dipp, MD PhD

Co-Founder & Managing Partner

Jennifer Lum

Co-Founder & Managing Partner

Lauren Schumaker

Senior Associate

 

Portfolio Companies

TBA

TBA

 

Select Prior Investments

Ginkgo Bioworks

 

Our Advisors

Sir John Bell

Advisor

Dr. Maulik Majmudar

Advisor

Bob Pozen

Advisor

Peter B. Henry

Advisor

Lisa Detwiler

Advisor

John Sexton

Advisor

Katie Burke

Operational Expert

Colin Raney

Operational Expert

Erin Dobson

Operational Expert

 

News

 

Biospring Partners Backs Drug Developer and Manufacturer Abzena

Private-equity firm Biospring Partners struck its first deal since being founded earlier this year, backing U.K.-based drug developer Abzena Ltd.
New York-based Biospring invested $10 million in the company and Michelle Dipp, the firm’s co-founder and managing partner, joined Abzena’s board of directors.

  • Twitter
  • LinkedIn
  • Instagram